Brincidofovir-d6

Description

Brincidofovir-d6 CMX001-d6 is the deuterium labeled Brincidofovir HY-14532 . Brincidofovir CMX001 , the lipid-conjugated prodrug of Cidofovir HY-17438 , is an orally available, long-acting antiviral. Brincidofovir shows activity against a broad spectrum of DNA viruses including cytomegalovirus CMV , adenovirus ADV , varicella zoster virus, herpes simplex virus, polyomaviruses, papillomaviruses, poxviruses, and mixed double-stranded DNA virus infections. Brincidofovir, an oral antiviral in late stage development, has proven effective against orthopoxviruses in vitro and in vivo..